Építés alatt – nem éles oldal
Belépés
Csak meghívásos3. fázis

Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia

A legfontosabb adatok

Hol
Anaheim, Atlanta, Austin, Boston, Brooklyn, Charleston, Chicago, Cromwell, Dallas, Duncansville, Hazelwood, Hollywood, Jacksonville, Knoxville, Lakeland, Las Vegas, Little Rock, Louisville, Memphis, Norcross, Oceanside, Orlando, Overland Park, Prairieville, Prosper, Redlands, Sacramento, Santa Ana, Springfield, Tampa, The Villages, Town and Country, Tulsa, Watertown és Williamsville (Egyesült Államok)Mind a 35 helyszín megnézése
Fázis
3. fázis

Helyszínek itt: Egyesült Államok

  • Anaheim, CaliforniaHospital not named in the registryNo longer taking part
  • Atlanta, GeorgiaHospital not named in the registryNo longer taking part
  • Austin, TexasHospital not named in the registryNo longer taking part
  • Boston, MassachusettsHospital not named in the registryNo longer taking part
  • Brooklyn, New YorkHospital not named in the registryNo longer taking part
  • Charleston, South CarolinaHospital not named in the registryNo longer taking part
  • Chicago, IllinoisHospital not named in the registryNo longer taking part
  • Cromwell, ConnecticutHospital not named in the registryNo longer taking part
  • Dallas, TexasHospital not named in the registryNo longer taking part
  • Duncansville, PennsylvaniaHospital not named in the registryNo longer taking part
  • Hazelwood, MissouriHospital not named in the registryNo longer taking part
  • Hollywood, FloridaHospital not named in the registryNo longer taking part
  • Jacksonville, FloridaHospital not named in the registryNo longer taking part
  • Knoxville, TennesseeHospital not named in the registryNo longer taking part
  • Lakeland, FloridaHospital not named in the registryNo longer taking part
  • Las Vegas, NevadaHospital not named in the registryNo longer taking part
  • Little Rock, ArkansasHospital not named in the registryNo longer taking part
  • Louisville, KentuckyHospital not named in the registryNo longer taking part
  • Memphis, TennesseeHospital not named in the registryNo longer taking part
  • Norcross, GeorgiaHospital not named in the registryNo longer taking part
  • Oceanside, CaliforniaHospital not named in the registryNo longer taking part
  • Orlando, FloridaHospital not named in the registryNo longer taking part
  • Overland Park, KansasHospital not named in the registryNo longer taking part
  • Prairieville, LouisianaHospital not named in the registryNo longer taking part
  • Prosper, TexasHospital not named in the registryNo longer taking part
  • Redlands, CaliforniaHospital not named in the registryNo longer taking part
  • Sacramento, CaliforniaHospital not named in the registryNo longer taking part
  • Santa Ana, CaliforniaHospital not named in the registryNo longer taking part
  • Springfield, MassachusettsHospital not named in the registryNo longer taking part
  • Tampa, FloridaHospital not named in the registryNo longer taking part
  • The Villages, FloridaHospital not named in the registryNo longer taking part
  • Town and Country, MissouriHospital not named in the registryNo longer taking part
  • Tulsa, OklahomaHospital not named in the registryNo longer taking part
  • Watertown, MassachusettsHospital not named in the registryNo longer taking part
  • Williamsville, New YorkHospital not named in the registryNo longer taking part

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Axsome Therapeutics, Inc.
Azonosító
NCT07637162
A regiszteradat frissítve
2026. november 6.
Eredeti leírás
This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the long-term safety and efficacy of AXS-14 in the management of fibromyalgia.A teljes eredeti leírásKevesebb

An Open-Label Study to Assess the Long-Term Safety and Efficacy of AXS-14 in the Management of Fibromyalgia

This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the long-term safety and efficacy of AXS-14 in the management of fibromyalgia.

Bevonási feltételek: Participation in AXS-14-FM-301.

Kizáró feltételek: Unable to comply with study procedures; Medically inappropriate for study participation in the opinion of the Investigator.

ClinicalTrials.gov NCT07637162